Stay updated with breaking news from China Repeat. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
路孚特追踪的数据显示，周四有40艘集装箱船在舟山外围锚地等待，比8月10日的30艘有所增加，当时梅东集装箱码头一名工人的新冠检测呈阳性。
* GRAPHIC - China's total available crude oil vs. Refinery throughput: https://tmsnrt.rs/36a1Bwj
By Reuters Staff (Repeats for wider distribution with no change to text) BEIJING, Dec 31 (Reuters) - China has given conditional approval for general public use to a COVID-19 vaccine developed by China National Biotec Group (CNBG), an official with China’s National Medical Products Commission told a media briefing on Thursday. The approval is the first for general public use among a handful of Chinese coronavirus vaccine candidates in various stages of development. Reporting by Roxanne Liu and Tony Munroe; Editing by Christian Schmollinger